{"transactions":[{"id":1021881,"issuer":{"id":7847,"kind":"organization","name":"TOMI Environmental Solutions, Inc."},"owners":[{"id":74440,"kind":"person","name":"Vanston David Cecil","position":1,"cik":"0001703012","reported_name":"Vanston David Cecil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-10-08T13:39:59.000Z","date":"2025-10-06","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a one-time sign-on award grant of time-based restricted stock units (\"RSU\"). Each RSU represents the contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock.  The RSUs are scheduled to vest equally in thirds on each of June 17, 2025, 2026, and 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) unvested 66,667 RSUs granted on October 6, 2025 and (ii) 33,333 shares of common stock owned by the reporting person."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001170022-25-000009","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/314227/000117002225000009/primary_doc.xml","form_type":"4"}},{"id":2933948,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":74440,"kind":"person","name":"Vanston David Cecil","position":1,"cik":"0001703012","reported_name":"Vanston David Cecil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-23T21:11:16.000Z","date":"2020-12-22","kind":"gift","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Daughter"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The option to purchase an aggregate of 50,000 shares of Common Stock of the Issuer was granted to Mr. Vanston on February 11, 2019 under the Issuer's 2015 Plan.  The option was transferred as a gift by Mr. Vanston to his daughter on December 22, 2020. Mr. Vanston disclaims beneficial ownership of the shares held by his daughter."}],"balance_after":50000,"derivative":{"exercise_price":3.25,"exercise_date":"2020-02-11","expiration_date":"2025-02-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001078782-20-001005","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878220001005/primary_doc.xml","form_type":"4"}},{"id":2933947,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":74440,"kind":"person","name":"Vanston David Cecil","position":1,"cik":"0001703012","reported_name":"Vanston David Cecil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-23T21:11:16.000Z","date":"2020-12-22","kind":"gift","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The option to purchase an aggregate of 50,000 shares of Common Stock of the Issuer was granted to Mr. Vanston on February 11, 2019 under the Issuer's 2015 Plan.  The option was transferred as a gift by Mr. Vanston to his daughter on December 22, 2020. Mr. Vanston disclaims beneficial ownership of the shares held by his daughter."}],"balance_after":0,"derivative":{"exercise_price":3.25,"exercise_date":"2020-02-11","expiration_date":"2025-02-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001078782-20-001005","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878220001005/primary_doc.xml","form_type":"4"}},{"id":2933946,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":74440,"kind":"person","name":"Vanston David Cecil","position":1,"cik":"0001703012","reported_name":"Vanston David Cecil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-23T21:11:16.000Z","date":"2020-12-22","kind":"gift","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Daughter"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option to purchase an aggregate of 60,000 shares of Common Stock of VolitionRx Limited (the \"Issuer\"), was granted to Mr. Vanston on January 23, 2018, under the Issuer's 2015 Stock Incentive Plan (the \"2015 Plan\").  The option was transferred as a gift by Mr. Vanston to his daughter on December 22, 2020. Mr. Vanston disclaims beneficial ownership of the shares held by his daughter."}],"balance_after":60000,"derivative":{"exercise_price":4,"exercise_date":"2019-01-23","expiration_date":"2024-01-23","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001078782-20-001005","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878220001005/primary_doc.xml","form_type":"4"}},{"id":2933945,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":74440,"kind":"person","name":"Vanston David Cecil","position":1,"cik":"0001703012","reported_name":"Vanston David Cecil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-23T21:11:16.000Z","date":"2020-12-22","kind":"gift","acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option to purchase an aggregate of 60,000 shares of Common Stock of VolitionRx Limited (the \"Issuer\"), was granted to Mr. Vanston on January 23, 2018, under the Issuer's 2015 Stock Incentive Plan (the \"2015 Plan\").  The option was transferred as a gift by Mr. Vanston to his daughter on December 22, 2020. Mr. Vanston disclaims beneficial ownership of the shares held by his daughter."}],"balance_after":0,"derivative":{"exercise_price":4,"exercise_date":"2019-01-23","expiration_date":"2024-01-23","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001078782-20-001005","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878220001005/primary_doc.xml","form_type":"4"}},{"id":3177007,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":74440,"kind":"person","name":"Vanston David Cecil","position":1,"cik":"0001703012","reported_name":"Vanston David Cecil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-15T21:05:23.000Z","date":"2020-04-13","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"A total of 60,000 Options were granted on April 13, 2020 under the Company's 2015 Stock Incentive Plan.  The Options vest in full twelve months from the date of grant."}],"balance_after":60000,"derivative":{"exercise_price":3.6,"exercise_date":"2021-04-13","expiration_date":"2026-04-13","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001078782-20-000264","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878220000264/primary_doc.xml","form_type":"4"}},{"id":3337916,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":74440,"kind":"person","name":"Vanston David Cecil","position":1,"cik":"0001703012","reported_name":"Vanston David Cecil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option (Right to Buy)","published_at":"2019-12-18T16:53:29.000Z","date":"2019-12-16","kind":"grant","acquired":true,"shares":66533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions involved a cancellation and reissuance of a portion of outstanding options upon agreement of the reporting person.  The \"old\" options were originally granted on April 10, 2017 and vested in full at 12 months from the date of grant, and were exercisable for five years from the date first exercisable.  The \"replacement\" options are fully-vested on the date of grant and have the same expiration date and exercise price as the \"old\" options."}],"balance_after":100000,"derivative":{"exercise_price":5,"exercise_date":"2019-12-16","expiration_date":"2023-04-10","underlying":"Common Stock","underlying_shares":66533},"source":{"system":"sec-edgar","filing":"0001078782-19-000927","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878219000927/primary_doc.xml","form_type":"4"}},{"id":3337915,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":74440,"kind":"person","name":"Vanston David Cecil","position":1,"cik":"0001703012","reported_name":"Vanston David Cecil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option (Right to Buy)","published_at":"2019-12-18T16:53:29.000Z","date":"2019-12-16","kind":"disposition_to_issuer","acquired":false,"shares":66533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions involved a cancellation and reissuance of a portion of outstanding options upon agreement of the reporting person.  The \"old\" options were originally granted on April 10, 2017 and vested in full at 12 months from the date of grant, and were exercisable for five years from the date first exercisable.  The \"replacement\" options are fully-vested on the date of grant and have the same expiration date and exercise price as the \"old\" options."}],"balance_after":33467,"derivative":{"exercise_price":5,"exercise_date":"2018-04-10","expiration_date":"2023-04-10","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001078782-19-000927","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878219000927/primary_doc.xml","form_type":"4"}},{"id":3662019,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":74440,"kind":"person","name":"Vanston David Cecil","position":1,"cik":"0001703012","reported_name":"Vanston David Cecil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2019-02-13T21:30:13.000Z","date":"2019-02-11","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"A total of 50,000 Options were granted on February 11, 2019 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant."}],"balance_after":50000,"derivative":{"exercise_price":3.25,"exercise_date":"2020-02-11","expiration_date":"2025-02-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001078782-19-000128","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878219000128/primary_doc.xml","form_type":"4"}},{"id":4090524,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":74440,"kind":"person","name":"Vanston David Cecil","position":1,"cik":"0001703012","reported_name":"Vanston David Cecil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-25T21:39:42.000Z","date":"2018-01-23","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"A total of 60,000 Options were granted on January 23, 2018 under the Company's 2015 Stock Incentive Plan.  The Options vest in full twelve months from the date of grant."}],"balance_after":60000,"derivative":{"exercise_price":4,"exercise_date":"2019-01-23","expiration_date":"2024-01-23","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001078782-18-000068","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878218000068/primary_doc.xml","form_type":"4"}},{"id":4206677,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":74440,"kind":"person","name":"Vanston David Cecil","position":1,"cik":"0001703012","reported_name":"Vanston David Cecil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"COMMON STOCK","published_at":"2017-09-19T20:28:47.000Z","date":"2017-09-19","kind":"purchase","acquired":true,"shares":2750,"price":2.84,"value":7810.0,"ownership":{"direct":true},"balance_after":2750,"source":{"system":"sec-edgar","filing":"0001078782-17-001281","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878217001281/primary_doc.xml","form_type":"4"}},{"id":4354917,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":74440,"kind":"person","name":"Vanston David Cecil","position":1,"cik":"0001703012","reported_name":"Vanston David Cecil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-04-11T20:11:00.000Z","date":"2017-04-10","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"A total of 100,000 Options were granted on April 10, 2017 under the Company's 2015 Stock Incentive Plan.  The Options vest in full twelve months from the date of grant."}],"balance_after":100000,"derivative":{"exercise_price":5,"exercise_date":"2018-04-10","expiration_date":"2023-04-10","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001078782-17-000451","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878217000451/primary_doc.xml","form_type":"4"}}]}